As reported to coloplast, though not verified, between (b)(6) 2018-(b)(6) 2019: uti.Urine culture showed 1,000-10,000 cfu/ml enterococcus faecalis and coagulase negative staphylococcus.Blood in urine.Urine culture shows 10,000-50,000 cfu/ml coagulase negative staphylococcus and (b)(6).Urinalysis showed moderate leukocyte esterase, 25-50 wbc and slight bacteria.Urine culture showed >100,000 cfu/ml staphylococcus aureus.Urinalysis showed large leukocytes.Unspecified mechanical complication of genitourinary device, implant and/or graft.Chronic utis, dysuria, sui, urgency, urge incontinence, frequency, nocturia, incomplete bladder emptying, lower pelvic/vaginal pressure, incontinent of stool, mesh erosion-bladder and abdominal wall, pain.On (b)(6) 2018- supris sling removal, urethral lysis, anterior colporrhaphy, abdominal paravaginal, removal of abdominal mesh, removal of mesh from the bladder, repair of bladder from mesh erosion, reinforcement of the bladder and urethral tissues with dermapure via general anesthesia for vaginal pain, bladder pain, abdominal pain, scarring, and mesh erosion.Pathology showed reactive fibrosis, chronic inflammation, and foreign body giant cell reaction surrounding polarizable foreign material, compatible with mesh.Leakage with stress and urge.Urgency, urge incontinence and stress incontinence, dysuria, nocturia, urinary frequency.On (b)(6) 2019-sling urethropexy with unknown mesh, cystocele repair, anterior colporrhaphy, rectocele repair, posterior colporrhaphy, colpoperineorrhaphy, and resection of redundant mons pubis done via general endotracheal anesthesia for sui, cystocele, rectocele, absent perineum, and redundant mons pubis.Light vaginal bleeding, slower urinary stream, difficulty emptying bladder, chills, dysuria.Urine culture done-no results.Uti symptoms.No other adverse patient effects were reported.
|